AU783933B2 - Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-MTDC) and/or physiologically compatible salts for treating and/or preventing cancers - Google Patents

Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-MTDC) and/or physiologically compatible salts for treating and/or preventing cancers Download PDF

Info

Publication number
AU783933B2
AU783933B2 AU39190/01A AU3919001A AU783933B2 AU 783933 B2 AU783933 B2 AU 783933B2 AU 39190/01 A AU39190/01 A AU 39190/01A AU 3919001 A AU3919001 A AU 3919001A AU 783933 B2 AU783933 B2 AU 783933B2
Authority
AU
Australia
Prior art keywords
methyl
thiazolidine
dicarboxylic acid
tolerable salts
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU39190/01A
Other languages
English (en)
Other versions
AU3919001A (en
Inventor
Hans Rommelspacher
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3919001A publication Critical patent/AU3919001A/en
Application granted granted Critical
Publication of AU783933B2 publication Critical patent/AU783933B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU39190/01A 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-MTDC) and/or physiologically compatible salts for treating and/or preventing cancers Ceased AU783933B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10008159 2000-02-15
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
PCT/DE2001/000656 WO2001060343A2 (de) 2000-02-15 2001-02-15 Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Publications (2)

Publication Number Publication Date
AU3919001A AU3919001A (en) 2001-08-27
AU783933B2 true AU783933B2 (en) 2005-12-22

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39190/01A Ceased AU783933B2 (en) 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-MTDC) and/or physiologically compatible salts for treating and/or preventing cancers

Country Status (15)

Country Link
US (2) US6943185B2 (zh)
EP (1) EP1255538B1 (zh)
JP (1) JP2003522782A (zh)
CN (1) CN1400899A (zh)
AT (1) ATE252383T1 (zh)
AU (1) AU783933B2 (zh)
CA (1) CA2399709C (zh)
DE (2) DE10008159B4 (zh)
EA (1) EA004592B1 (zh)
ES (1) ES2208571T3 (zh)
MX (1) MXPA02007903A (zh)
PL (1) PL357179A1 (zh)
PT (1) PT1255538E (zh)
TR (1) TR200302134T4 (zh)
WO (1) WO2001060343A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
KR100717098B1 (ko) * 2002-02-28 2007-05-10 니뽄 다바코 산교 가부시키가이샤 에스테르 화합물 및 그 의약 용도
EP1669345A4 (en) * 2003-08-29 2008-02-20 Japan Tobacco Inc ESTER DERIVATIVE AND MEDICAL USE THEREOF
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
MX2007004973A (es) * 2004-10-25 2007-06-14 Japan Tobacco Inc Formulacion solida con solubilidad y estabilidad mejoradas y metodo para producir la formulacion.
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE19711053C2 (de) 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEOPLASMA 43(4):259-263, WLODEK B ET AL, 1996 *

Also Published As

Publication number Publication date
CA2399709A1 (en) 2001-08-23
ES2208571T3 (es) 2004-06-16
ATE252383T1 (de) 2003-11-15
US20030149085A1 (en) 2003-08-07
EA004592B1 (ru) 2004-06-24
CN1400899A (zh) 2003-03-05
DE50100833D1 (de) 2003-11-27
EP1255538B1 (de) 2003-10-22
WO2001060343A3 (de) 2002-05-30
US6943185B2 (en) 2005-09-13
DE10008159A1 (de) 2001-09-06
CA2399709C (en) 2007-05-15
DE10008159B4 (de) 2005-08-18
EA200200853A1 (ru) 2003-02-27
PL357179A1 (en) 2004-07-26
PT1255538E (pt) 2004-03-31
WO2001060343A2 (de) 2001-08-23
EP1255538A2 (de) 2002-11-13
US20050187271A1 (en) 2005-08-25
AU3919001A (en) 2001-08-27
JP2003522782A (ja) 2003-07-29
TR200302134T4 (tr) 2004-01-21
MXPA02007903A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
US20050187271A1 (en) Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or its physiologically tolerable salts as a cancer-fighting agent
Tang et al. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies
JP7009053B2 (ja) 有機セレン化合物の組成物およびその使用方法
US6815434B2 (en) Methods for treating hearing loss
EP2023911B1 (de) Verbindungen a-r-x zur herstellung von pharmazeutischen zubereitungen
WO2009052116A1 (en) Methods for treating a variety of diseases and conditions, and compounds useful therefor
KR100949318B1 (ko) 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물
JP2004502743A (ja) 薬学的化合物の還元体の製造、安定化および使用
US20190307726A1 (en) Pharmaceutical formulations
KR20230107890A (ko) 정신병적 장애를 치료하기 위한 방법 및 조성물
AU2007204757B2 (en) Lanthionine-related compounds for the treatment of inflammatory diseases
US20120202860A2 (en) Analgesic Compounds, Compositions and Uses Thereof
Waniewski et al. Intrahippocampal kainic acid reduces glutamine synthetase
WO2021198216A1 (en) New method to treat the hepatotoxicity induced by amanitins
RU2813928C1 (ru) Антиоксидантный препарат для лечения и профилактики неврологических патологий у животных
JP4734560B2 (ja) キノン体若しくはキノン体前駆体の毒性に起因する障害に対する予防治療剤
WO2020262317A1 (ja) 認知症の治療及び予防薬
US20090298782A1 (en) Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof
KR20160019321A (ko) 포르포빌리노겐을 유효성분으로 포함하는 암 치료용 약학적 조성물

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase